Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Cohen

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 9, 2008
[New drugs; natalizumab]H van Bronswijk, E A Dubois, J M A van Gerven, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranololJ M van Griensven, M Seibert-Grafe, H C Schoemaker, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepamA F Cohen, L Ashby, D Crowley, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2014
The use of biomarkers in human pharmacology (Phase I) studiesA F Cohen, J Burggraaf, J M A van Gerven, et al.
Clinical Science (London, England : 1979)|May 1, 1994
Influence of 1-desamino-8-D-vasopressin on endogenous fibrinolysis, haemodynamics and liver blood flow in healthy subjectsJ Burggraaf, H C Schoemaker, J M Kroon, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamineA F Cohen, M J Hamilton, S H Liao, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsG J H Dumont, S J de Visser, A F Cohen, et al.
Clinical Pharmacology and Therapeutics|January 1, 1993
Characterization of glutathione conjugation in humans: stereoselectivity in plasma elimination pharmacokinetics and urinary excretion of (R)- and (S)-2-bromoisovalerylurea in healthy volunteersT M Mulders, V Venizelos, R Schoemaker, et al.
Journal of Clinical Pharmacology|November 10, 1998
Lack of interaction between tramadol and coumarinsJ K Boeijinga, E van Meegen, R van den Ende, et al.
British Journal of Clinical Pharmacology|September 19, 2002
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarinR A Faaij, J Burggraaf, R C Schoemaker, et al.
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
Nederlands Tijdschrift Voor Geneeskunde|April 9, 2008
[New drugs; natalizumab]H van Bronswijk, E A Dubois, J M A van Gerven, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranololJ M van Griensven, M Seibert-Grafe, H C Schoemaker, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepamA F Cohen, L Ashby, D Crowley, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2014
The use of biomarkers in human pharmacology (Phase I) studiesA F Cohen, J Burggraaf, J M A van Gerven, et al.
Clinical Science (London, England : 1979)|May 1, 1994
Influence of 1-desamino-8-D-vasopressin on endogenous fibrinolysis, haemodynamics and liver blood flow in healthy subjectsJ Burggraaf, H C Schoemaker, J M Kroon, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamineA F Cohen, M J Hamilton, S H Liao, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsG J H Dumont, S J de Visser, A F Cohen, et al.
Clinical Pharmacology and Therapeutics|January 1, 1993
Characterization of glutathione conjugation in humans: stereoselectivity in plasma elimination pharmacokinetics and urinary excretion of (R)- and (S)-2-bromoisovalerylurea in healthy volunteersT M Mulders, V Venizelos, R Schoemaker, et al.
Journal of Clinical Pharmacology|November 10, 1998
Lack of interaction between tramadol and coumarinsJ K Boeijinga, E van Meegen, R van den Ende, et al.
British Journal of Clinical Pharmacology|September 19, 2002
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarinR A Faaij, J Burggraaf, R C Schoemaker, et al.
Pageof 22